Emory University Orchard Therapeutics PLC Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$10.15 - $15.58 $1.1 Million - $1.69 Million	-108,692 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$11.88 - $16.72 $174,731 - $245,917	-14,708 Reduced 11.92%	108,692 $1.29 Million
Q2 2019 Aug 14, 2019	SELL	$13.2 - $20.63 $435,613 - $680,810	-33,001 Reduced 21.1%	123,400 $1.73 Million
Q1 2019 May 09, 2019	BUY	$12.01 - $19.49 $1.88 Million - $3.05 Million	156,401 New	156,401 $2.8 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.